Northwestern Mutual Wealth Management’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio GERM Stock Details GERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4	Closed	-$90	–	3636
2022 Q4	$90	Buy	+4	New	+$90	﹤0.01%	3229
2022 Q3	–	Sell	-200	Closed	-$5K	–	3473
2022 Q2	$5K	Buy	+200	New	+$4.76K	﹤0.01%	2737

Other funds holding GERM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northwestern Mutual Wealth Management's GERM Position: Q1 2023 in Review

Northwestern Mutual Wealth Management sold out of Amplify Treatments, Testing and Advancements ETF (GERM) in Q1 2023, closing a stake of 4 shares — an estimated $90 sold.

Northwestern Mutual Wealth Management first reported a position in GERM in Q2 2022 and held it in 2 quarters. The position peaked at $5K in Q2 2022. 19 funds tracked by Wall St. Rank hold GERM as of Q1 2023.

Northwestern Mutual Wealth Management reported no remaining Amplify Treatments, Testing and Advancements ETF position as of Q1 2023 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 4 Amplify Treatments, Testing and Advancements ETF shares in Q1 2023, an estimated $90.
Northwestern Mutual Wealth Management first reported a position in Amplify Treatments, Testing and Advancements ETF in Q2 2022 and held it in 2 quarters.
Northwestern Mutual Wealth Management's Amplify Treatments, Testing and Advancements ETF position peaked at $5K in Q2 2022.
19 funds tracked by Wall St. Rank held Amplify Treatments, Testing and Advancements ETF as of Q1 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2023, filed 15 May 2023.